- Home
- REPL vs CCSI Comparison
REPL vs CCSI Comparison
Compare REPL & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REPL | CCSI |
|---|---|---|
| Founded | 2015 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 692.8M | 561.4M |
| IPO Year | 2018 | 2022 |
Fundamental Metrics
Financial Performance| Metric | REPL | CCSI |
|---|---|---|
| Price | $7.65 | $23.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | $11.13 | ★ $37.50 |
| AVG Volume (30 Days) | ★ 1.4M | 127.3K |
| Earning Date | 05-21-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.25 | N/A |
| EPS | N/A | ★ 4.35 |
| Revenue | N/A | ★ $349,696,000.00 |
| Revenue This Year | N/A | $3.64 |
| Revenue Next Year | N/A | $3.37 |
| P/E Ratio | ★ N/A | $5.44 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.68 | $17.84 |
| 52 Week High | $13.24 | $31.67 |
Technical Indicators
Market Signals| Indicator | REPL | CCSI |
|---|---|---|
| Relative Strength Index (RSI) | 52.32 | 31.31 |
| Support Level | $6.71 | $20.51 |
| Resistance Level | $8.07 | $24.25 |
| Average True Range (ATR) | 0.49 | 1.26 |
| MACD | 0.04 | -0.75 |
| Stochastic Oscillator | 80.07 | 10.08 |
Price Performance
Historical ComparisonAbout REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.